Cargando…
Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation
Intestinal mucositis is a commonly reported side effect in oncology practice. Probiotics are considered an excellent alternative therapeutic approach to this debilitating condition; however, there are safety questions regarding the viable consumption of probiotics in clinical practice due to the ris...
Autores principales: | Batista, Viviane Lima, De Jesus, Luís Cláudio Lima, Tavares, Laísa Macedo, Barroso, Fernanda Lima Alvarenga, Fernandes, Lucas Jorge da Silva, Freitas, Andria dos Santos, Americo, Monique Ferrary, Drumond, Mariana Martins, Mancha-Agresti, Pamela, Ferreira, Enio, Laguna, Juliana Guimarães, Alcantara, Luiz Carlos Júnior, Azevedo, Vasco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324481/ https://www.ncbi.nlm.nih.gov/pubmed/35889136 http://dx.doi.org/10.3390/microorganisms10071418 |
Ejemplares similares
-
Probiogenomics of Lactobacillus delbrueckii subsp. lactis CIDCA 133: In Silico, In Vitro, and In Vivo Approaches
por: de Jesus, Luís Cláudio Lima, et al.
Publicado: (2021) -
Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway
por: Barroso, Fernanda Alvarenga Lima, et al.
Publicado: (2022) -
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
por: Batista, Viviane Lima, et al.
Publicado: (2020) -
Intake of Lactobacillus delbrueckii (pExu:hsp65) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis
por: Barroso, Fernanda Alvarenga Lima, et al.
Publicado: (2021) -
Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
por: Martyniak, Adrian, et al.
Publicado: (2021)